← Back to Search

Amino Acid

Amino Acid Intake for Healthy Subjects

N/A
Waitlist Available
Led By Daniel Moore, Ph.D
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hours
Awards & highlights

Study Summary

Protein Requirements in Male and Female Endurance Athletes

Eligible Conditions
  • Increased Metabolic Rate
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Phenylalanine excretion
Secondary outcome measures
Phenylalanine Oxidation
Phenylalanine net balance
Other outcome measures
Protein requirement
Urinary 3-methylhistidine

Trial Design

3Treatment groups
Experimental Treatment
Group I: Moderate ProteinExperimental Treatment1 Intervention
1.2g/kg/day of protein provided as crystalline amino acid made after egg protein.
Group II: Low ProteinExperimental Treatment1 Intervention
0.2 g/kg/day of protein provided as crystalline amino acid made after egg protein.
Group III: High ProteinExperimental Treatment1 Intervention
2.0 g/kg/day of protein provided as crystalline amino acid made after egg protein.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amino Acid Intake
2016
N/A
~50

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,627 Total Patients Enrolled
Daniel Moore, Ph.DPrincipal InvestigatorUniversity of Toronto
1 Previous Clinical Trials
14 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025